SWOG S1922 Primary Category: Treatment Protocols Disease Category: Gastrointestinal, Small Bowel Status: Open Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma NCT#04205968 (Click for More Info)